Title:
CHIRAL DINAPSOLINE
Document Type and Number:
WIPO Patent Application WO/2003/013532
Kind Code:
A1
Abstract:
The present invention relates to the preparation of the optical isomer (R)-(+)-8,9-dihydroxy-2,3,7,11b-tetrahydro-1H-napth[1,2,3-de]isoquinoline. This invention also relates to the use of pharmaceutical compositions comprising (R)-(+)-8,9-dihydroxy-2,3,7,11b-tetrahydro-1H-napth[1,2,3-de]isoquinoline for use for the treatment of movement disorders.
Inventors:
SIT SING-YUEN (US)
Application Number:
PCT/US2002/025267
Publication Date:
February 20, 2003
Filing Date:
August 08, 2002
Export Citation:
Assignee:
PURDUE RESEARCH FOUNDATION (US)
SIT SING-YUEN (US)
SIT SING-YUEN (US)
International Classes:
A61K31/473; A61P3/04; A61P25/00; A61P25/14; A61P25/16; A61P25/24; A61P25/36; A61P43/00; C07D221/18; (IPC1-7): A61K31/473; C07D221/18
Domestic Patent References:
| WO1997006799A1 | 1997-02-27 |
Other References:
See also references of EP 1414457A4
Attorney, Agent or Firm:
Lammert, Steven R. (IN, US)
Download PDF:
Previous Patent: PHENYL DERIVATIVES AS FACTOR XA INHIBITORS
Next Patent: METHODS FOR IMPROVED TREATMENT OF CANCER WITH IRINOTECAN BASED ON MRP1
Next Patent: METHODS FOR IMPROVED TREATMENT OF CANCER WITH IRINOTECAN BASED ON MRP1